Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $81.07 and last traded at $81.07, with a volume of 6150 shares traded. The stock had previously closed at $81.07.
Pharma Mar Price Performance
The firm’s 50 day moving average price is $74.24 and its two-hundred day moving average price is $50.74. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Featured Stories
- Five stocks we like better than Pharma Mar
- What Are Dividends? Buy the Best Dividend Stocks
- Micron Stock Under $100: Seize the AI-Driven Upside
- The Role Economic Reports Play in a Successful Investment Strategy
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Top Stocks Investing in 5G Technology
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
